Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb;14(1):31-33.
doi: 10.15420/icr.2018.28.2.

How to Make the TAVI Pathway More Efficient

Didier Tchetche  1 , Chiara de Biase  1 , Bruno Brochado  1 , Antonios Mastrokostopoulos  1
Affiliations
Review

How to Make the TAVI Pathway More Efficient

Didier Tchetche et al. Interv Cardiol. 2019 Feb.

Abstract

Transcatheter aortic valve implantation (TAVI) has been in use for 16 years. As there has been a rapid expansion in its use, there is a need to optimise TAVI programmes to ensure efficiency. In this article, the authors discuss the reasons why clinicians need to make the TAVI pathway more efficient and describe the most important steps to take from screening to early discharge, including procedural optimisation.

Keywords: Early discharge; TAVI; efficiency; simplification; transcatheter aortic valve implantation.

PubMed Disclaimer

Conflict of interest statement

Disclosure: DT is a consultant for Edwards LifeSciences, Medtronic and Boston Scientific. All other authors have no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Before and After the Optimisation of Human Resources During Transfemoral TAVI
See this image and copyright information in PMC

References

    1. Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8. doi: 10.1161/01.CIR.0000047200.36165.B8. - DOI - PubMed
    1. Durand E, Borz B, Godin M et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv. 2012;5:461–7. doi: 10.1016/j.jcin.2012.01.018. - DOI - PubMed
    1. Gilard M, Eltchaninoff H, Iung B et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705–15. doi: 10.1056/NEJMoa1114705. - DOI - PubMed
    1. Mylotte D, Osnabrugge RLJ, Windecker S et al. Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization. J Am Coll Cardiol. 2013;62:210–9. doi: 10.1016/j.jacc.2013.03.074. - DOI - PubMed
    1. Tchetche D, Van Mieghem NM. New-generation TAVI devices: description and specifications. EuroIntervention. 2014;10(Suppl U):U90–100. doi: 10.4244/EIJV10SUA13. - DOI - PubMed